| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | NW9K8C1JN3 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | Programmed cell death 1 ligand 1 binding agent |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
| Lung Neoplasms | 3 | D008175 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Mesothelioma | 2 | D008654 | ClinicalTrials |
| Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
| Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Gallbladder Neoplasms | 2 | D005706 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Urogenital Neoplasms | 2 | D014565 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Cholangiocarcinoma | 2 | D018281 | ClinicalTrials |
| Thymoma | 2 | D013945 | ClinicalTrials |
| Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
| Cholangiocarcinoma | 2 | D018281 | ClinicalTrials |
| Esophageal Neoplasms | 2 | D004938 | ClinicalTrials |
| Head and Neck Neoplasms | 1 | D006258 | ClinicalTrials |
| Small Cell Lung Carcinoma | 1 | D055752 | ClinicalTrials |
| Sarcoma, Kaposi | 1 | D012514 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
| Stomach Neoplasms | 1 | D013274 | ClinicalTrials |
| Triple Negative Breast Neoplasms | 1 | D064726 | ClinicalTrials |
| Oropharyngeal Neoplasms | 1 | D009959 | ClinicalTrials |
| Penile Neoplasms | 1 | D010412 | ClinicalTrials |
| Vaginal Neoplasms | 1 | D014625 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4298024 |
| FDA SRS | NW9K8C1JN3 |